This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Bo Brismar, MD; Christian Hrdstedt, MD; Stefan Jacobson, MD; Lars Kager, MD; Anna-Stina Malmborg, MD

Arch Surg. 1982;117(9):1196-1199.

Abstract
• A prospective trial was carried out to test the hypothesis that therapy with intravenous (IV) heparin sodium reduces the incidence of thrombotic complications related to the use of central venous catheters for parenteral nutrition. The patients studied were randomly allocated either to a group given heparin sodium, at a dosage of 5,000 IU/6 hr, or to a control group that received no heparin prophylaxis. The heparin group comprised 23 catheter periods (22 patients), and the control group 26 catheter periods (25 patients). In five of the 23 catheters in the heparin group and 14 of the 26 in the control group, catheter phlebography revealed thrombus formation in association with the catheter when this was removed. The results indicated that the use of IV heparin as prophylaxis against thrombosis reduced the risk of thrombus formation on the central venous catheter.

(Arch Surg 1982;117:1196-1199)

Author Affiliations
From the Departments of Surgery (Drs Brismar, Jacobson, and Kager), Roentgenology (Dr Hrdstedt), and Clinical Microbiology (Dr Malmborg), Huddinge Hospital, Karolinska Institute, Stockholm.

Footnotes
Accepted for publication April 20, 1982.

Reprint requests to Department of Surgery, Huddinge Hospital, S-141 86 Huddinge, Sweden (Dr Brismar).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Randomized, Controlled Trial of Heparin Versus Placebo Infusion to Prolong the Usability of Peripherally Placed Percutaneous Central Venous Catheters (PCVCs) in Neonates: The HIP (Heparin Infusion for PCVC) Study
Shah et al.
Pediatrics 2007;119:e284-e291.
ABSTRACT | FULL TEXT  

Randomized Trial of Prevention of Catheter-Related Bloodstream Infection by Continuous Infusion of Low-Dose Unfractionated Heparin in Patients With Hematologic and Oncologic Disease
Abdelkefi et al.
JCO 2005;23:7864-7870.
ABSTRACT | FULL TEXT  

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients
Verso and Agnelli
JCO 2003;21:3665-3675.
ABSTRACT | FULL TEXT  

Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter: A Systematic Review
Klerk et al.
Arch Intern Med 2003;163:1913-1921.
ABSTRACT | FULL TEXT  

Thromboembolic Disease and Antithrombotic Therapy in Newborns
Andrew et al.
ASH Education Book 2001;2001:358-374.
ABSTRACT | FULL TEXT  

Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials
Randolph et al.
BMJ 1998;316:969-975.
ABSTRACT | FULL TEXT